Answers are grounded in this paper and cite their sources.
OBJECTIVE: Limited data exist on suicidality among non-treatment-seeking individuals with opioid dependence in low- and middle-income countries. The objectives of the study were to assess the prevalence and correlates of suicidality and perceived burdensomeness among community-dwelling individuals with opioid dependence and to assess association of socio-clinical factors with suicidality and perceived burdensomeness. METHODS: This cross-sectional study utilized baseline data from a prospective community-based cohort study conducted in an urban socioeconomically disadvantaged area of Delhi, India. Adult males meeting ICD-10 criteria for opioid dependence and not engaged in treatment for at least 6 months were recruited using snowball sampling. Suicidality was assessed using the Ask Suicide-Screening Questions (ASQ). Depressive symptoms (using Patient Health Questionnaire-9), anxiety symptoms (Generalized Anxiety Disorder-7), severity of opioid dependence (Leeds Dependence Questionnaire), and high-risk behaviors were evaluated. Logistic regression analyses were conducted to identify factors independently associated with suicidality and perceived burdensomeness. CONCLUSIONS: Suicidality is highly prevalent among non-treatment-seeking individuals with opioid dependence in community settings. Co-occurring depressive and anxiety symptoms significantly contribute to suicide risk, underscoring the critical importance of integrated mental health screening within opioid use disorder services. Early identification and intervention targeting psychiatric comorbidity may reduce suicide risk in this vulnerable dual diagnosis population.
No takes yet. Share an insight, caveat, or question.
Shakya et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: